COVID-19 Related Coagulopathy: A Distinct Entity?
Fiche publication
Date publication
mai 2020
Journal
Journal of clinical medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr SCHINI-KERTH Valérie
Tous les auteurs :
Marchandot B, Sattler L, Jesel L, Matsushita K, Schini-Kerth V, Grunebaum L, Morel O
Lien Pubmed
Résumé
The coronavirus disease 2019 (COVID-19) pandemic has impacted healthcare communities across the globe on an unprecedented scale. Patients have had diverse clinical outcomes, but those developing COVID-19-related coagulopathy have shown a disproportionately worse outcome. This narrative review summarizes current evidence regarding the epidemiology, clinical features, known and presumed pathophysiology-based models, and treatment guidance regarding COVID-19 coagulopathy.
Mots clés
COVID-19, antiphospholipid antibodies, coronavirus disease 2019, endothelium, hemostasis, microparticles, thrombosis
Référence
J Clin Med. 2020 May 31;9(6):